Navigation Links
Recent Patient Series Demonstrates Spirus Medical's Power Spiral Endoscope Enables Unprecedented Access to GI Tract
Date:10/15/2010

STOUGHTON, Mass., Oct. 15 /PRNewswire/ -- Spirus Medical, Inc. (www.spirusmed.com), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology announces a series of pan-endoscopies in an average time of 60 minutes, using a flexible endoscope with an integral drive to power a single use spiral component. The initial clinical series, which was conducted outside the U.S., showed unparalleled ability to navigate the intestinal tract.

In the clinical studies, procedures were performed from a combined anal and oral route. Of the series of ten pan-endoscopies, one examined the entire small bowel from the oral route in 24 minutes; another examined the entire small bowel from the anal route in 30 minutes. Current endoscopic modalities rarely accomplish complete GI examinations and often require several hours when they do.

"The power spiral endoscope is a truly game-changing technology that has immediate applications in how gastroenterologists evaluate intestinal disorders, with an additional range of potential applications in patients with surgically-altered anatomy—e.g., bariatric surgery," said Dr. Oleh Haluszka, Director, GI Endoscopy at Fox Chase Cancer Center, Philadelphia. Using the powered scope for the first time, Dr. Haluszka was able to negotiate the GI tract from mouth to colon in 24 minutes.

Spirus Medical has developed the Endo-Ease® line of devices aimed at revolutionizing GI endoscopy which are extensively used today to access remote areas in the small bowel and in the colon. The power spiral endoscope is the latest innovation of the technology which integrates the spiral mechanism directly into a flexible scope. In the study, powered spiral endoscopy demonstrated rapid and complete GI access and could give physicians the ability to diagnose and treat immediately as compared to having the patient return for multiple diagnostic and/or therapeutic procedures.

Physicians participating in the initial study believe the power spiral endoscope's ability to rapidly diagnose and treat intestinal lesions makes it a candidate to quickly supplant capsule endoscopy. The latter technology has been found to have numerous drawbacks according to the clinicians, including the fact that capsule endoscopy is often inconclusive and patients are required to undergo a second procedure for treatment if pathology is identified in the first round of examination.

"The extremely successful clinical evaluations over the last several months made it clear that we have created a powerful endoscopic tool that will be a disruptive force in the GI marketplace. It will create a paradigm shift that will change the way endoscopy is performed," said Steven Tallarida, President and CEO. "Best of all, the initial response from the clinicians experienced with power spiral suggest there will be a substantial medical benefit for millions of patients worldwide."

The power spiral endoscope opportunity includes a capital equipment component (scope/ light source/processor) as well as a disposable spiral component which is replaced after each use. "The power spiral can immediately capitalize on a $100 million market opportunity for the disposable spiral component alone," said Bob Ailinger, COO of Spirus. According to iData Research, projected growth in the marketplace over the next five years will create a commercial opportunity estimated at $500 million just in the small bowel segment of the overall market.

Spirus Medical, Inc.

Spirus Medical is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing its flexible endoscope with an integral drive to power a single use spiral component. For more information on Spirus Medical, visit www.spirusmed.com.


'/>"/>
SOURCE Spirus Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix Appoints Chief Information Officer
2. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
3. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
4. Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges
5. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
6. Lost and Found: L2FU Recovers 100% of Clinical Trial Patients for Recent Pivotal Study
7. China Medical Technologies Announces the Recent Publication of a Study on its SPR Analyzer and HPV DNA Chip in Cancer Genetics and Cytogenetics and the Creation of a Medical Publications Column to the Investor Relations Section on its Website
8. Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes
9. Cardium Reports on Fourth Quarter and Year-End 2009 Financial Results and Recent Developments
10. Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance
11. VHGI Discusses Recent Addition to the Regulation SHO Threshold Security Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):